Printer Friendly

Hyperreactive malarious splenomegaly and aids: a case report.

Introduction

Hyperreactive malarious splenomegaly (HMS), known as Tropical Splenomegaly Syndrome, (1) despite being common in malaria-endemic regions and in travelers from non-endemic areas, (2) has low prevalence in Brazil. (3) The HMS is presented as an exaggerated immune response to infection by Plasmodium, resulting in nonspecific, hyper-immunoglobulin M (IgM) polyclonal immunoglobulin production by B lymphocytes, and the formation of immune complexes that are deposited in the spleen. The criteria for the diagnosis of HMS are: splenomegaly (>10 cm below the left costal margin), increased IgM that exceeds twice the reference value, high titers of antibodies specific against Plasmodium sp. and clinical-laboratory improvement after treatment with anti-malarial drugs. (4,5) The association with HIV infection is poorly documented, although HIV and malaria are endemic in many tropical regions.

Case report

A 50-year-old man was admitted to the infectious diseases sector of UHL (University Hospital of Londrina, Brazil) in February 2012. On admission, he complained of progressive weight loss, asthenia, and abdominal discomfort for two months, associated with fever for three days.

Physical examination showed discrete hepatomegaly and significant splenomegaly, about 20 cm below the left costal margin. He reported having lived in the cities of Londrina/PR and Itaituba/PA, where he worked in mining for about seven months a year. He had a previous history of 20 episodes of malaria, and had been diagnosed with HIV in the past two years, with irregular use of antiretroviral therapy. Laboratory tests on admission showed: Hb = 5.6g/dL, platelets = 61,000/[mm.sup.3]; leukocytes = 4300/[mm.sup.3] (67% neutrophils), protein electrophoresis with hypergamma-globulinemia =51%; albumin = 2.5 g/dL; IgM= 1790mg/dL (NR: 57-212), CD4= 115/[mm.sup.3] and viral load = 2352 copies/mL. Antibody (indirect immunofluorescence) anti-plasmodium vivax was 1/1280 and anti-plasmodium falciparum = 1/320. The direct method for Plasmodium sp. thick smear was negative, as well as polymerase chain reaction (PCR). On admission, the first diagnostic hypothesis was sepsis after urinary tract infection. Once E. coli bacteria were isolated from blood and urine, the treatment with Ciprofloxacin had good response, but the urinary infection could not explain the splenomegaly.

Mieloculture was performed and fungi and Leishmania in two samples were searched, both turned out negative, ruling out histoplasmosis and visceral leishmaniasis. Inoculation in mice bone marrow blood resulted negative for Leishmania. Parasitical exams were negative in feces.

On admission, serology for toxoplasmosis and cytomegalovirus had positive IgM for both microorganisms, which ultimately proved to be false-positive. Likewise, anti-HCV was positive at low titers, with negative PCR for HCV.

Abdominal tomography showed a 3700 mL spleen at admission and 9 months after initiation of treatment, it reduced to 1358 mL (64% reduction), demonstrating homogeneous parenchymal liver and spleen without portal hypertension (Figs. 1 and 2).

Having defined the diagnosis of HMS the first cycle with primaquine and chloroquine was carried out for 7 days, followed by chloroquine 300 mg/week. Follow-up exams in the first and ninth month are shown in Table 1.

Discussion and conclusion

The development of HMS is associated with two main factors: repeated exposure to Plasmodium species and genetic predisposition. Countries with high endemism for malaria have prevalence of HMS ranging from 1 to 2% in Nigeria and 80% in certain tribes of New Papua Guinea. (2) In Brazil, the prevalence is low in the Amazon region. (3) Alecrim (6) examined a population of 890 people living in a hyper-endemic area of Manaus, and found only 10 people with a persistent spleen enlargement. Of these, four met the criteria for Tropical Splenomegaly, as it was known at the time, three of them were brothers, underscoring the importance of genetic predisposition in tribal HMS.

The main genetic factors related to high population prevalence of HMS were HLA-DR2 and high levels of HLA heterozygous, (4,7) in addition to the high frequency of the hap lotype IGHG3. (8)

It is believed that patients with HMS have a hyper production of polyclonal IgM, (1) which is linked to suppressor T lymphocytes (cytotoxic phenotype), causing the elimination of the parasite, as well as generating immune complexes that are deposited in the spleen, thus resulting in splenomegaly.

In this case, the overproduction of nonspecific polyclonal IgM explains the false positive results for both cytomegalovirus and toxoplasmosis, in addition to high titers of IgM (one of the diagnostic criteria).

The diagnosis of tropical splenomegaly syndrome requires exclusion of other causes of massive splenomegaly. However, definite diagnosis depends on specific criteria, such as the Fakunle (4,5,9) criteria shown in Table 2. These criteria are not different for HIV patients. (10) In the case herein reported, the patient met all major criteria in addition to hypersplenism as a minor criterion, thus confirming the diagnosis.

Although HIV/AIDS and malaria coexist with high prevalence in many countries of sub-Saharan Africa, few cases have been published linking the two diseases. (10,11) In individuals with AIDS there is an inversion in the CD4/CD8 ratio due to decrease in number and function of CD4T lymphocytes, while in HMS there is an increase in this ratio due to decreased number of CD8T lymphocytes. One hypothesis is that this difference may prevent patients with HIV from manifesting HMS after repeated Malaria infections, explaining therefore the low number of cases associating the two diseases. However, further studies should be carried out to better identify the immunological relationship between them.

HMS treatment consists of a short cycle of anti-malarial drug, and the use of chemoprophylaxis (chloroquine in this case) for a period of 9-26 months in patients who remain exposed to malaria, to prevent new infections and to have the described immunomodulatory effect of chloroquine. (12)

Therefore, we must be alert to cases of massive splenomegaly in patients living in endemic areas of malaria in Brazil, or those who migrated from these regions. Furthermore, HMS needs to be considered as a differential diagnosis in patients with splenomegaly and AIDS.

ARTICLE INFO

Article history:

Received 21 March 2014

Accepted 21 April 2014

Available online 6 June 2014

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgment

We would like to thank Andre Machado Siqueira from Universidade Estadual do Amazonas (Amazonas State University) for the suport in malaria PCR.

REFERENCES

(1.) Bryceson A, Fakunle YM, Fleming AF, et al. Malaria and splenomegaly (letter). Trans R Soc Trop Med Hyg. 1983;77: 879.

(2.) Crane GG. Recent studies of hyperreactive malarious splenomegaly (tropical splenomegaly syndrome) in Papua New Guinea. PNG Med J. 1986;29:35-40.

(3.) Doencas Infecciosas e Parasitarias: Enfoque Amazonico/Raimundo Nonato Queiroz de Leao {coordenador}. Belem: Cejup, UEPA, Instituto Evandro Chagas; 1997.

(4.) Fakunle YM. Tropical splenomegaly. Clin Hematol. 1981;10:963-75.

(5.) Bates I, Bedu-Addo G. Review of diagnostic criteria of hyperreactive malarial splenomegaly. Lancet. 1997;349: 1179.

(6.) Alecrim, WD. Estudo clinico e epidemiologico da malaria no Rio Ituxi-Amazonas. 1979. 115p. Tese (mestrado). Universidade de Brasiilia, Brasilia. 1979.

(7.) Bhatia KK, Crane GG. HLA heterozygosity and hyperreactive malarious splenomegaly in the Upper Watut Valley of Nova Guinea. P N G Med J. 1989;32:277-86.

(8.) Kelly KM. IGHG3 G and the pathogenesis of hyperreactive malarious splenomegaly. Med Hypotheses. 1996;46:135-9.

(9.) Ranjan K, Singh. Hyperreactive malarial splenomegaly in expatriates. Travel Med Infect Dis. 2007;5:24-9.

(10.) De Iaco G, Saleri N, Perandin F, et al. Case Report. Hyper-reactive malarial splenomegaly in a patient with human immunodeficiency virus. Am J Trop Med Hyg. 2008;78:239-40.

(11.) Lowenthal MN, Horowitz J, Gaspar N, et al. Hyperreactive malarial splenomegaly and AIDS: proguanil prevents recurrent pneumonia. Trans R Soc Trop Med Hyg. 1996;90:313-4.

(12.) Hoffman SL, Piessens WF, Ratiwayanto S, et al. Reduction of suppressor T lymphocytes in the tropical splenomegaly syndrome. N Engl J Med. 1984;310:337-41.

Zuleica Naomi Tano (a), *, Chafic Esper Kallas Filho (b), Regina Mitsuka Bregano (c), Wander Rogerio Pavanelli (c), Uheyna Gancedo Ruzon (b)

(a) Departamento de Clinica Medica, Universidade Estadual de Londrina, Londrina, PR, Brazil

(b) Universidade Estadual de Londrina, Londrina, PR, Brazil

(c) Departamento de Ciencias Patologicas, Universidade Estadual de Londrina, Londrina, PR, Brazil

* Corresponding author.

E-mail addresses: zntanno@terra.com.br, naomi.tano@gmail.com (Z.N. Tano).

http://dx.doi.org/10.1016/j.bjid.2014.04.005

Table 1--Laboratory tests.

                          Admission   1 month     9 month

Hb (g/dL)                      5.6         10.2       13.7
Platelets/mL              56,000      100,000     99,000
Leukocytes ([mu]/L)         4300         3500       5800
IgM (mg/dL)                 1790           --        473
Protein electrophoresis       51           35.8       30
  (Hypergamma %)
Albumin (g/dL)                 2.5          4.5        4.68
Spleen volume               3700           --       1358
  CT abdomen (vol/mL)

Table 2--Diagnostic feature of hyperreactive malarious
splenomegaly (HMS)--Fakunle criteria.

Major criteria                  Minor criteria

Splenomegaly > 10 cm            Hepatic sinusoidal
                                lymphocytosis
IgM > 2SD of local mean         Hypersplenism
High titers of antimalarial     Lymphocytic proliferation
antibodies
Clinical and immunological      Normal cellular and humoral
response to antimalarial drug   immune response to antigenic
                                challenge excluding
                                Plasmodium
                                Occurrence within families
                                and tribes
COPYRIGHT 2014 Contexto
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Case report
Author:Tano, Zuleica Naomi; Filho, Chafic Esper Kallas; Bregano, Regina Mitsuka; Pavanelli, Wander Rogerio;
Publication:The Brazilian Journal of Infectious Diseases
Article Type:Clinical report
Date:Sep 1, 2014
Words:1485
Previous Article:Rothia aeria endocarditis in a patient with a bicuspid aortic valve: case report.
Next Article:Orf disease: a report of a case.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |